Reed-Sternberg cell present in a biopsy specimen of lymph node tissue
Computed tomography (CT) scans of the chest and abdomen to assess for involvement of mediastinal, abdominal, and pelvic lymph nodes
A bipedal lymphangiogram to detect structural changes in the lymph nodes too small to visualize on CT scan
A positron emission tomography (PET) imaging
A bilateral bone marrow biopsy may be performed if disease is disseminated.
Staging of Non-Hodgkin Lymphomas
Disease
Bone marrow biopsy
Blood studies
Chest and abdominal CT scans
Nuclear medicine studies
Cytologic examination of the cerebrospinal fluid
Treatment for Hodgkin and NHL Types
Radiation Combination chemotherapy
For NHL only
Adjuvant radiation therapy
Monoclonal antibodies
Depends on the histologic type, stage of the disease, and clinical status of the person
Leukemias
Definition: Malignant neoplasms arising from the transformation of a single blood cell line derived from hematopoietic stem cells
Classification according to cell lineage
Lymphocytic (lymphocytes)
Myelocytic (granulocytes, monocytes)
Chronic Leukemias
Definition: Malignancies involving the proliferation of well-differentiated myeloid and lymphoid cells
Types of chronic leukemia
Chronic lymphocytic leukemia (CLL)
Chronic myelogenous leukemia (CML)
Classification of Leukemia Types
Acute lymphocytic (lymphoblastic) leukemia (ALL)
Both involve immature lymphocytes and their progenitors in the bone marrow, the spleen, lymph nodes, CNS, and other tissue.
Chronic lymphocytic leukemia (CLL)
Acute myelogenous (myeloblastic) leukemia (AML)
Both involve the pluripotent myeloid stem cells in bone marrow and interfere with the maturation of all blood cells.
Chronic myelogenous leukemia (CML)
Goals of Treatment for CML
A hematological response characterized by normalized blood counts
A cytogenetic response demonstrated by the reduction or elimination of the Ph chromosome from the bone marrow
A molecular response confirmed by the elimination of the BCR-ABL fusion protein
Criteria for Remission of ALL and AML
Less than 5% blasts in the bone marrow
Normal peripheral blood counts
Absence of cytogenetic abnormalities
Return to preillness performance status
Factors Affecting the Likelihood of Achieving Remission
Age (most significant prognostic variable)
Type of leukemia
Stage of the disease at time of presentation
Leukemic Cells
Are immature and poorly differentiated
Proliferate rapidly and have a long life span
Do not function normally
Interfere with the maturation of normal blood cells
Circulate in the blood stem
Cross the blood–brain barrier
Infiltrate many body organs
Warning Signs Complications of Acute Leukemia
Signs
Fatigue
Pallor
Weight loss
Repeated infections
Easy bruising
Nosebleeds
Other types of hemorrhage
Complications
Leukostasis
Tumor lysis syndrome
Hyperuricemia
Blast crisis
Multiple Myeloma
Definition: A plasma cell dyscrasia characterized by expansion of a single clone of immunoglobulin -producing plasma cells and a resultant increase in serum levels of a single monoclonal immunoglobulin or its fragments
Main sites involved
The bones and bone marrow
Proliferation and activation of osteoclasts that lead to bone resorption and destruction